Daily Equity Report 13 AUGUST 2019

1. CAPITALSTARS FINANCIAL RESEARCH PVT. LTD. CapitalStars Investment Adviser: SEBI Registration Number: INA000001647 DAILY EQUITY REPORT 13 THAUGUST 2019 Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.

2. CAPITALSTARS FINANCIAL RESEARCH PVT. LTD. Daily Equity Report INDIAN FACE INDIAN MARKET CLOSE PREVIOUS ! 37327.36 INDIAN EQUITY BENCHMARK -Indian indices ended higher for second consecutive day but off day's high on August 9 with Nifty holding above 11,100 level. At close, NIFTY 11032.45 Sensex was up 254.55 points at 37,581.91, while Nifty was CLOSE PREVIOUS up 77.20 points at 11,109.70. About 1521 shares have NIKKEI 20593.35 advanced, 952 shares declined, and 151 shares are unchanged. Indiabulls Housing, Eicher Motors, Maruti 26120.77 Suzuki, Bajaj Finserv and Titan Company were among major 1937.75 gainers on the Nifty, while losers were Yes Bank, Cipla, SECTORIAL INDICES Hindalco Industries, Tech Mahindra and Coal India. Among INDICES CLOSE sectors, IT, metal, PSU bank and pharma witnessed selling CNX 100 11222.20 pressure, while buying seen in the auto, FMCG and energy S&P CNX 500 sectors. GLOBAL FACE CNX 200 ! BANK NIFTY 28431.90 Asian Market - Asian markets finished mixed as of the most recent closing prices. The Nikkei 225 gained 0.44%, while the Shanghai Composite led the Hang Seng lower. They fell 0.71% TOP GAINERS and 0.59% respectively. CLOSE CHANGE (%) ! U.S. Market – North and South American markets finished broadly higher on Thursday with shares in Brazil leading the region. The Bovespa is up 1.91% while U.S.'s S&P 500 is up TITAN 1.88% and Mexico's IPC is up 0.02%. MARUTI ! TOP LOSERS European markets – European markets are broadly higher today with shares in France leading the region. The CAC 40 is CLOSE up 1.22% while Germany's DAX is up 0.76% and London's FTSE 100 is up 0.18%. YESBANK CIPLA 485.10 -3.57 TECHM 663.00 -2.53 HINDALCO 177.00 -2.24 Daily Equity Report Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.

3. CAPITALSTARS FINANCIAL RESEARCH PVT. LTD. NIFTY SPOT MARKET MOVERS UPSIDE CHANGE (%) STRATEGY SELL ON RISE SCRIPT CLOSE IBULHSGFIN PIVOT POINTS P 11117 S3 10880 S2 10999 S1 R1 11173 R2 11236 RESISTANCE R1-11250 R2-11400 R3 11355 2.32 HDFCBANK 11054 2.02 SUPPORT S1-11000 S2-10850 KOTAKBNK 1531.75 1.93 MARKET MOVERS DOWNSIDE CLOSE (%) -7.85 YESBANK 82.20 COALINDIA -2.15 -1.51 ITC -1.34 NET BUY (CR.) NET INSTITUTION SELL (CR) FII 5866.00 3901.32 TREND STRATEGY SELL ON RISE NSE TOTALS PIVOT POINTS P 28483 SUPPORT DECLINE S S2 28189 S1 28342 R2 R3 29072 INDICES 27894 28636 28778 RESISTANCE R1-28750 R2-28900 NIFTY BANK NIFTY 9 2 Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.

4. CAPITALSTARS FINANCIAL RESEARCH PVT. LTD. Daily Equity Report ! ! MRF zooms ~5% as cons. PAT rises 3% yoy to Rs273.3cr in Q1FY20 Britannia Ind. adjusted PAT up 3% yoy to Rs267cr in Q1FY20 Britannia Industries Ltd. (BIL), Indias leading Food Company, reported its Q1FY20 results today. The company's consolidated revenue rose 6% yoy for the quarter to Rs2, 677cr. Adjusted Net Profit increased by 3% yoy to Rs267cr (Reported Net profit at Rs251cr).On the cost front, the company witnessed moderate inflation in the prices of key raw materials for the bakery business. However, the inordinate rise in milk prices impacted profitability of the company's Dairy business adversely. Shares of tyre major MRF are trading ~5% higher after reporting Q1 results for the quarter ended June 2019. The company's consolidated net profit rose 3% yoy to Rs273.3cr against Rs260.7cr. Its revenue grew 16.5% yoy at Rs4, 471cr vs. Rs3, 836.3cr. EBITDA rose 6.3% yoy at Rs612.3cr and EBDITA margin was at 13.7%. ! Alembic Pharma gets USFDA tentative approval for Bimatoprost Ophthalmic Solution, 0.01% Alembic Pharmaceuticals Limited announced that the Company has received tentative approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application Ophthalmic Solution, 0.01%. The tentatively approved ANDA is therapeutically equivalent to the reference listed drug product (RLD), LUMIGAN ophthalmic solution 0.01%, of Allergan Inc. Bimatoprost Ophthalmic Solution, 0.01% is indicated for the reduction of elevated intraocular pressure in patients with open angle glaucoma or ocular hypertension. Bimatoprost Ophthalmic Solution, 0.01% has an estimated market size of $704mn for twelve months ending December 2018 according to IQVIA. (ANDA) for Bimatoprost ! Mahanagar Gas reports ~33% yoy jump in PAT for Q1FY20 Shares of Mahanagar Gas are down ~3% after opening up 2% in early trade. The company posted its Q1FY20 results on Thursday. Mahanagar Gas' net profit rose 32.66% yoy to Rs170.24cr in the quarter under review. Revenue went up on 22.55% yoy at Rs777.83cr for the June quarter. The board in its meeting also approved the appointment of Dr. Ashutosh Karnatak as an additional Director (Non-Executive & Non Independent) and Chairman of the Company effective from August 01, 2019. Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.

5. CAPITALSTARS FINANCIAL RESEARCH PVT. LTD. Daily Equity Report NAME OF THE STOCK : MOTHERSUMI DATE : 13/08/2019 SEGMENT : CASH CHART TYPE : Candlestick EXCHANGE : NSE TECHNICAL INDICATORS USED : VOLUME.MACD,RSI. CHART INVESTMENT ADVICE: CALL CS CALL:- BUY MOTHERSUMI IN CASH ABOVE 107.35 TGT 110 SL 104 RATIONALE FOR ARRIVING INVESTMENT ADVICE : TECHNICAL VIEW : THE STOCK TECHINCALLY IS UP ,TAKING SUPPORT OF VOLUME.RESISTANCE IS BROKEN TODAY WITH HEAVY VOLUME.AS WELL AS A POSSIBILITY OF UPWARD MOVEMENT IS THERE. OTHER REASON IF ANY :- SHOWING STRENGTHS IN INTRADAY CHARTS AS WELL Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.

6. CAPITALSTARS FINANCIAL RESEARCH PVT. LTD. DISCLAIMER The information and views in this report & all the service we provide are believed to be reliable, but we do not accept any responsibility for errors of fact or opinion. Investors have the right to choose the product/s that suits them the most. Sincere efforts have been made to present the right investment perspective. The information contained herein is based on analysis and up on sources that we consider reliable. This material is for personal information and based upon it & takes no responsibility. The information given herein should be treated as only factor, while making investment decision. The report does not provide individually tailor-made investment advice. My research recommends that investors independently evaluate particular investments and strategies, and encourages investors to seek the advice of a financial adviser. CapitalStars shall not be responsible for any transaction conducted based on the information given in this report, which is in violation of rules and regulations of regulators. The price projections shown are not necessarily indicative of future price performance. The information herein, together with all estimates and forecasts, can change without notice. It is understood that anyone who is browsing through the site has done so at his free will and does not read any views expressed as a recommendation for which either the site or its owners or anyone can be held responsible for. Investment & Trading in Securities Markets are always subjected to market risk. CapitalStars Financial Research Private Ltd., Reserves all Rights. INVESTMENT AND TRADING IN SECURITIES MARKET IS ALWAYS SUBJECTED TO MARKET RISK. Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.

7. CAPITALSTARS FINANCIAL RESEARCH PVT. LTD. CapitalStars Financial Research Private Limited is an advisory company incepted with a vision of providing fair and accurate trading and investment calls in share and commodity market. we specialize in thorough fundamental and technical research analysis in equity and commodity market to provide best equity and commodity tips to traders and investors. we provide intraday as well as delivery stock tips in NSE and BSE and commodity tips in MCX and NCDEX. Get our more services:- Mcx Tips Financial advisory company Sharemarket company Stock Tips Investment & Trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance. CapitalStars Investment Adviser: SEBI Registration Number: INA000001647

8. CAPITALSTARS FINANCIAL RESEARCH PVT. LTD. BRANCH OFFICE Capitalstars Financial Research Private Limited PLOT NO.32, MECHANIC NAGAR EXTENSION,IDA SCHEME NO.54,VIJAYNAGAR INDORE REGISTERED OFFICE PLOT NO.12, SCHEME NO.78 PART-2, VIJAY NAGAR, INDORE Email:-backoffice@capiltalstars.in Contact us :- 9977499927, 9039012727 Report Is Checked by Investment Advisor: Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.